just as the clarity of high definition television has transformed the entertainment world, Siemens Medical Solutionsis redefining the quality of molecular imaging with the introduction of high definition positron emission tomography.
In what could prove to be a turning point in diagnosis and therapy for millions of patients suffering from neurological diseases, stroke and cancer, Siemens Medical Solutions showed results of a prototype for the world¡¦s first fully-functioning imaging system capable of performing simultaneously Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET). The first in-vivo human brain simultaneous MR-PET images were acquired in the Siemens facilities in USA. Testing of this new prototype MR-PET will start before the end of 2007.
Siemens announces the latest innovation in electrophysiology (EP) solutions with the introduction of syngo® DynaCT Cardiac, which enables 3D imaging comparable to computed tomography (CT) in the EP lab during procedures. Building upon Siemens’ breakthrough syngo DynaCT technology, this solution enhances diagnostic and therapeutic capabilities by enabling electrophysiologists for the first time to visualize the left atrium in 3D during complex cardiac procedures, virtually eliminating the need for time-consuming pre-procedural CT or magnetic resonance imaging (MRI) exams. syngo DynaCT Cardiac will be featured in the Siemens booth (# 129) at the 28th Annual Scientific Sessions of the Heart Rhythm Society from May 9 through May 12 in Denver.
The old adage says “a picture is worth 1,000 words,” but that value is undoubtedly higher in preclinical research where high-resolution images can validate years of work. Siemens Medical Solutions, Molecular Imaging division, manufacturer of the Inveon™ preclinical imaging system, continues to lead the preclinical imaging market, through a strong investment in its research partners and through the demand for the versatile and upgradeable Inveon platform.
Cancer-sensing devices built as cheaply and efficiently as wristwatches - using many of the same operating principles - could change the way clinicians detect, treat and monitor cancer in patients. Researchers from the Georgia Institute of Technology have created an acoustic sensor that can report the presence of small amounts of mesothelin, a molecule associated with a number of cancers including mesothelioma, as they attach to the sensor's surface.
Siemens Medical Solutions USA, Inc. and Xintek Inc. announce today that they have signed an agreement to establish a joint venture company in Research Triangle Park, N.C. The mission of the new company, named XinRay Systems, is to develop a new multi-pixel X-ray source technology for a broad range of diagnostic imaging applications.
We've never seen anything quite like it," says solar physicist Lika Guhathakurta from NASA headquarters.
Targeting the inflammation caused by VEGF could give better quality of life to patients affected by this progressive disease, say UK scientists
By placing quantum dots on a specially designed photonic
crystal, researchers at the University of Illinois have
demonstrated enhanced fluorescence intensity by a factor of up to 108.
Potential applications include high-brightness light-emitting diodes,
optical switches and personalized, high-sensitivity biosensors.
BIOIDENT Technologies Inc., the leading
company in the development of printed opto-electronic solutions for life sciences, today
announced that the company is a co-winner in the semiconductor category for the
seventh annual Wall Street Journal contest for Technology Innovation. BIOIDENT was
awarded for the development of its PhotonicLab Platform™, which enables rapid in-vitro
diagnostics, chemical and biological threat detection, and environmental testing without
the need for off-site lab analysis.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.